(6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione

C42H57F3N8O6 — CID 166145569

IUPAC(6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione
SMILESCO[C@@H](C)c1ncc(N2CCN3CCOCC3C2)cc1-c1c2c3cc(ccc3n1CC(F)(F)F)N1CCO[C@@H](C[C@H](N)C(=O)N3CCC[C@H](N3)C(=O)OCC(C)(C)C2)C1
InChIInChI=1S/C42H57F3N8O6/c1-26(56-4)37-32(17-28(20-47-37)50-11-10-49-12-14-57-23-29(49)21-50)38-33-19-41(2,3)25-59-40(55)35-6-5-9-53(48-35)39(54)34(46)18-30-22-51(13-15-58-30)27-7-8-36(31(33)16-27)52(38)24-42(43,44)45/h7-8,16-17,20,26,29-30,34-35,48H,5-6,9-15,18-19,21-25,46H2,1-4H3/t26-,29?,30-,34-,35-/m0/s1
InChIKeyXPICDRCNBDCLHZ-KTPCNFJDSA-N
MW826.96 g/mol
LogP4.04
Rot. Bonds5

About (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione

(6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione (PubChem CID 166145569) has the molecular formula C42H57F3N8O6 and a molecular weight of 826.96 g/mol. Its IUPAC name is (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione.

Molecular Properties

Compound Name(6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione
PubChem CID166145569
Molecular FormulaC42H57F3N8O6
Molecular Weight826.96 g/mol
Exact Mass826.44
IUPAC Name(6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione
SMILESCO[C@@H](C)c1ncc(N2CCN3CCOCC3C2)cc1-c1c2c3cc(ccc3n1CC(F)(F)F)N1CCO[C@@H](C[C@H](N)C(=O)N3CCC[C@H](N3)C(=O)OCC(C)(C)C2)C1
InChIInChI=1S/C42H57F3N8O6/c1-26(56-4)37-32(17-28(20-47-37)50-11-10-49-12-14-57-23-29(49)21-50)38-33-19-41(2,3)25-59-40(55)35-6-5-9-53(48-35)39(54)34(46)18-30-22-51(13-15-58-30)27-7-8-36(31(33)16-27)52(38)24-42(43,44)45/h7-8,16-17,20,26,29-30,34-35,48H,5-6,9-15,18-19,21-25,46H2,1-4H3/t26-,29?,30-,34-,35-/m0/s1
InChIKeyXPICDRCNBDCLHZ-KTPCNFJDSA-N
XLogP4.04
TPSA139.89 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds5
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500826.96
LogP ≤ 54.04
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Analyze (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione?
The IUPAC name of (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione (CID 166145569) is (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione.
What is the SMILES notation for (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione?
The canonical SMILES for (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione is CO[C@@H](C)c1ncc(N2CCN3CCOCC3C2)cc1-c1c2c3cc(ccc3n1CC(F)(F)F)N1CCO[C@@H](C[C@H](N)C(=O)N3CCC[C@H](N3)C(=O)OCC(C)(C)C2)C1.
What is the InChIKey of (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione?
The InChIKey is XPICDRCNBDCLHZ-KTPCNFJDSA-N. The full InChI is InChI=1S/C42H57F3N8O6/c1-26(56-4)37-32(17-28(20-47-37)50-11-10-49-12-14-57-23-29(49)21-50)38-33-19-41(2,3)25-59-40(55)35-6-5-9-53(48-35)39(54)34(46)18-30-22-51(13-15-58-30)27-7-8-36(31(33)16-27)52(38)24-42(43,44)45/h7-8,16-17,20,26,29-30,34-35,48H,5-6,9-15,18-19,21-25,46H2,1-4H3/t26-,29?,30-,34-,35-/m0/s1.
What are the key properties of (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione?
(6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione has a molecular weight of 826.96 g/mol, XLogP of 4.04, 5 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (6S,8S,14S)-21-[5-(3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-8-amino-18,18-dimethyl-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraene-9,15-dione is sourced from PubChem (CID 166145569), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).